Immunotherapy-intensified paraneoplastic dermatomyositis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Indian journal of dermatology, venereology and leprology - 88(2021), 1 vom: 30. Jan., Seite 93-96 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Estenaga, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
52CMI0WC3Y |
|---|
| Anmerkungen: |
Date Completed 16.03.2022 Date Revised 16.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.25259/IJDVL_1306_20 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330340379 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330340379 | ||
| 003 | DE-627 | ||
| 005 | 20231225211058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.25259/IJDVL_1306_20 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330340379 | ||
| 035 | |a (NLM)34491672 | ||
| 035 | |a (PII)10.25259/IJDVL_1306_20 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Estenaga, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunotherapy-intensified paraneoplastic dermatomyositis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.03.2022 | ||
| 500 | |a Date Revised 16.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Immune Checkpoint Inhibitors |2 NLM | |
| 650 | 7 | |a atezolizumab |2 NLM | |
| 650 | 7 | |a 52CMI0WC3Y |2 NLM | |
| 700 | 1 | |a Rodriguez-Garijo, N |e verfasserin |4 aut | |
| 700 | 1 | |a Tomás-Velázquez, A |e verfasserin |4 aut | |
| 700 | 1 | |a Antoñanzas-Pérez, J |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez-Gigli, M L |e verfasserin |4 aut | |
| 700 | 1 | |a García-Tobar, L |e verfasserin |4 aut | |
| 700 | 1 | |a Espaa-Alonso, A |e verfasserin |4 aut | |
| 700 | 1 | |a Salido-Vallejo, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of dermatology, venereology and leprology |d 1976 |g 88(2021), 1 vom: 30. Jan., Seite 93-96 |w (DE-627)NLM076778096 |x 0973-3922 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2021 |g number:1 |g day:30 |g month:01 |g pages:93-96 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.25259/IJDVL_1306_20 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2021 |e 1 |b 30 |c 01 |h 93-96 | ||